NO922182L - Krystallinske oksatiolan-derivater - Google Patents
Krystallinske oksatiolan-derivaterInfo
- Publication number
- NO922182L NO922182L NO92922182A NO922182A NO922182L NO 922182 L NO922182 L NO 922182L NO 92922182 A NO92922182 A NO 92922182A NO 922182 A NO922182 A NO 922182A NO 922182 L NO922182 L NO 922182L
- Authority
- NO
- Norway
- Prior art keywords
- oxatatolan
- crystallinic
- derivatives
- oxatatolan derivatives
- crystallinic oxatatolan
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D411/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Secondary Cells (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB919111902A GB9111902D0 (en) | 1991-06-03 | 1991-06-03 | Chemical compounds |
Publications (3)
Publication Number | Publication Date |
---|---|
NO922182D0 NO922182D0 (no) | 1992-06-02 |
NO922182L true NO922182L (no) | 1992-12-04 |
NO301713B1 NO301713B1 (no) | 1997-12-01 |
Family
ID=10696001
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO922182A NO301713B1 (no) | 1991-06-03 | 1992-06-02 | Krystallinske oksatiolan-derivater |
Country Status (31)
Country | Link |
---|---|
US (1) | US5905082A (no) |
EP (2) | EP0517145B1 (no) |
JP (1) | JP2851480B2 (no) |
KR (1) | KR100244008B1 (no) |
AP (1) | AP300A (no) |
AT (1) | ATE212630T1 (no) |
AU (2) | AU656379B2 (no) |
BG (1) | BG60914B1 (no) |
CA (2) | CA2311988C (no) |
CZ (1) | CZ284513B6 (no) |
DE (1) | DE69232387T2 (no) |
DK (1) | DK0517145T3 (no) |
ES (1) | ES2171158T3 (no) |
GB (1) | GB9111902D0 (no) |
GE (1) | GEP19991834B (no) |
HK (1) | HK1009599A1 (no) |
IE (2) | IE921780A1 (no) |
IL (1) | IL102073A (no) |
IS (2) | IS1867B (no) |
MX (1) | MX9202619A (no) |
NO (1) | NO301713B1 (no) |
NZ (1) | NZ242981A (no) |
OA (1) | OA09913A (no) |
PT (1) | PT517145E (no) |
RU (1) | RU2102393C1 (no) |
SG (1) | SG52455A1 (no) |
SK (1) | SK281249B6 (no) |
TW (1) | TW254939B (no) |
UA (1) | UA41265C2 (no) |
WO (1) | WO1992021676A1 (no) |
ZA (1) | ZA924007B (no) |
Families Citing this family (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4581979A (en) * | 1983-07-01 | 1986-04-15 | Automotive Products Plc | Shipping and installation restraining clip for master cylinder input member |
US6642245B1 (en) | 1990-02-01 | 2003-11-04 | Emory University | Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane |
US6069252A (en) * | 1990-02-01 | 2000-05-30 | Emory University | Method of resolution and antiviral activity of 1,3-oxathiolane nucleoside enantiomers |
US5276151A (en) * | 1990-02-01 | 1994-01-04 | Emory University | Method of synthesis of 1,3-dioxolane nucleosides |
US5204466A (en) * | 1990-02-01 | 1993-04-20 | Emory University | Method and compositions for the synthesis of bch-189 and related compounds |
US5444063A (en) * | 1990-12-05 | 1995-08-22 | Emory University | Enantiomerically pure β-D-dioxolane nucleosides with selective anti-Hepatitis B virus activity |
US6812233B1 (en) | 1991-03-06 | 2004-11-02 | Emory University | Therapeutic nucleosides |
US5817667A (en) * | 1991-04-17 | 1998-10-06 | University Of Georgia Research Foudation | Compounds and methods for the treatment of cancer |
GB9116601D0 (en) * | 1991-08-01 | 1991-09-18 | Iaf Biochem Int | 1,3-oxathiolane nucleoside analogues |
US6177435B1 (en) | 1992-05-13 | 2001-01-23 | Glaxo Wellcome Inc. | Therapeutic combinations |
US20020120130A1 (en) | 1993-09-10 | 2002-08-29 | Gilles Gosselin | 2' or 3' -deoxy and 2', 3' -dideoxy-beta-L-pentofuranonucleo-side compounds, method of preparation and application in therapy, especially as anti- viral agents |
US5587362A (en) * | 1994-01-28 | 1996-12-24 | Univ. Of Ga Research Foundation | L-nucleosides |
IL115156A (en) | 1994-09-06 | 2000-07-16 | Univ Georgia | Pharmaceutical compositions for the treatment of cancer comprising 1-(2-hydroxymethyl-1,3-dioxolan-4-yl) cytosines |
US6391859B1 (en) | 1995-01-27 | 2002-05-21 | Emory University | [5-Carboxamido or 5-fluoro]-[2′,3′-unsaturated or 3′-modified]-pyrimidine nucleosides |
US5703058A (en) * | 1995-01-27 | 1997-12-30 | Emory University | Compositions containing 5-fluoro-2',3'-didehydro-2',3'-dideoxycytidine or a mono-, di-, or triphosphate thereof and a second antiviral agent |
US5808040A (en) * | 1995-01-30 | 1998-09-15 | Yale University | L-nucleosides incorporated into polymeric structure for stabilization of oligonucleotides |
ES2276404T3 (es) | 1995-06-07 | 2007-06-16 | Emory University | Nucleosidos con actividad antivirus de la hepatitis-b. |
US5914332A (en) * | 1995-12-13 | 1999-06-22 | Abbott Laboratories | Retroviral protease inhibiting compounds |
EP0938321B1 (en) | 1996-06-25 | 2004-01-14 | Glaxo Group Limited | Combinations comprising vx478, zidovudine and 3tc for use in the treatment of hiv |
US5753789A (en) * | 1996-07-26 | 1998-05-19 | Yale University | Oligonucleotides containing L-nucleosides |
TW536403B (en) * | 1997-03-24 | 2003-06-11 | Glaxo Group Ltd | An ethanol and ethylenediaminetetraacetic acid free pharmaceutical composition comprising lamivudine and exhibiting antimicrobial preservative efficacy |
US6436948B1 (en) | 2000-03-03 | 2002-08-20 | University Of Georgia Research Foundation Inc. | Method for the treatment of psoriasis and genital warts |
WO2003079972A2 (en) | 2002-02-22 | 2003-10-02 | New River Parmaceuticals Inc. | Active agent delivery systems and methods for protecting and administering active agents |
KR101015510B1 (ko) * | 2001-03-01 | 2011-02-16 | 길리애드 사이언시즈, 인코포레이티드 | 시스-ftc의 다형 및 기타 결정형 |
CA2351049C (en) | 2001-06-18 | 2007-03-13 | Brantford Chemicals Inc. | Process for recovery of the desired cis-1,3-oxathiolane nucleosides from their undesired trans-isomers |
WO2003027106A1 (en) * | 2001-09-25 | 2003-04-03 | Cadila Healthcar Limited | Process for the preparation of crystalline polymorph ii of lamivudine |
US20050287177A1 (en) * | 2002-11-08 | 2005-12-29 | Glaxo Group Unlimited And Smithkline Beecham Corp. | Pharmaceutical compositions |
AU2004206821C1 (en) | 2003-01-14 | 2009-10-01 | Gilead Sciences, Inc. | Compositions and methods for combination antiviral therapy |
DE602005011321D1 (de) * | 2004-11-10 | 2009-01-08 | Novartis Vaccines & Diagnostic | Deamidiertes interferon-beta |
US20060242012A1 (en) * | 2005-04-22 | 2006-10-26 | Sumit Agarwal | Determining or scoring properties to solicit to join ad network using advertiser or aggregated advertiser interest |
TWI471145B (zh) | 2005-06-13 | 2015-02-01 | Bristol Myers Squibb & Gilead Sciences Llc | 單一式藥學劑量型 |
TWI375560B (en) | 2005-06-13 | 2012-11-01 | Gilead Sciences Inc | Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same |
ES2357159T3 (es) * | 2006-04-18 | 2011-04-19 | Lupin Ltd. | Forma cristalina novedosa de lamivudina. |
WO2009031026A2 (en) * | 2007-09-06 | 2009-03-12 | Combino Pharm, S.L. | Novel pharmaceutical compositions |
WO2009037538A2 (en) * | 2007-09-17 | 2009-03-26 | Aurobindo Pharma Ltd | Process for the preparation of lamivudine form i |
CN101918393A (zh) * | 2007-11-29 | 2010-12-15 | 兰贝克赛实验室有限公司 | 拉米夫定的晶形i及其制备方法 |
SI2225232T1 (sl) * | 2007-11-29 | 2012-12-31 | Ranbaxy Laboratories Limited | Postopek za pripravo substituiranih 1,3-oksatiolanov |
BRPI0820224A2 (pt) * | 2007-11-29 | 2015-06-16 | Ranbaxy Lab Ltd | Composto de fórmula iii ou seus estereoisômeros; processo para sua preparação e seu uso; uso de um composto de formula iii(a) ou iii(b) em um processo para a preparação de lamivudina de fórmula i(a) ou um composto de fórmula i(c); processo para preparação de lamivudina de fórmula i(a) |
WO2009127996A1 (en) * | 2008-04-17 | 2009-10-22 | Ranbaxy Laboratories Limited | Novel crystalline form of lamivudine |
US8536151B2 (en) | 2008-09-01 | 2013-09-17 | Hetero Research Foundation | Process for preparing lamivudine polymorph form |
WO2010055526A1 (en) * | 2008-11-12 | 2010-05-20 | Lupin Limited | A novel polymorph of emtricitabine and a process for preparing of the same |
CN101993439B (zh) * | 2009-03-24 | 2013-04-24 | 福建广生堂药业股份有限公司 | 拉米夫定晶型及其制备方法 |
CN101531656B (zh) * | 2009-03-24 | 2010-12-08 | 福建广生堂药业有限公司 | 拉米夫定晶型及其制备方法 |
EP2435052B1 (en) * | 2009-05-27 | 2015-07-15 | Hetero Research Foundation | Solid oral dosage forms of lamivudine with isomalt |
EP2454244B1 (en) | 2009-07-15 | 2013-06-26 | Lupin Limited | An improved process for preparation of efavirenz |
ES2540074T3 (es) | 2009-10-14 | 2015-07-08 | Mylan Laboratories Limited | Proceso para la preparación de lamivudina y nuevas sales en la fabricación de la misma |
TR201807704T4 (tr) | 2010-01-27 | 2018-06-21 | Viiv Healthcare Co | Anti-viral tedavi. |
WO2011095987A1 (en) * | 2010-02-03 | 2011-08-11 | Matrix Laboratories Ltd. | Novel process for the preparation of cis-nucleoside derivative |
JP2013519676A (ja) * | 2010-02-12 | 2013-05-30 | メルク・シャープ・エンド・ドーム・コーポレイション | ラミブジン形態iの調製 |
EP2579892A2 (en) | 2010-06-09 | 2013-04-17 | Vaccine Technologies, Incorporated | Therapeutic immunization in hiv infected subjects receiving stable antiretroviral treatment |
WO2013021290A1 (en) | 2011-08-05 | 2013-02-14 | Lupin Limited | A stereoselective process for preparation of 1,3-oxathiolane nucleosides |
WO2013168066A1 (en) | 2012-05-05 | 2013-11-14 | Lupin Limited | An improved process for the manufacture of lamivudine form i. |
CN114099454B (zh) * | 2020-08-31 | 2023-06-27 | 长春海悦药业股份有限公司 | 一种拉米夫定片及其制备方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5047407A (en) * | 1989-02-08 | 1991-09-10 | Iaf Biochem International, Inc. | 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties |
US5204466A (en) * | 1990-02-01 | 1993-04-20 | Emory University | Method and compositions for the synthesis of bch-189 and related compounds |
GB9009861D0 (en) * | 1990-05-02 | 1990-06-27 | Glaxo Group Ltd | Chemical compounds |
US5179104A (en) * | 1990-12-05 | 1993-01-12 | University Of Georgia Research Foundation, Inc. | Process for the preparation of enantiomerically pure β-D-(-)-dioxolane-nucleosides |
US5248776A (en) * | 1990-12-05 | 1993-09-28 | University Of Georgia Research Foundation, Inc. | Process for enantiomerically pure β-L-1,3-oxathiolane nucleosides |
-
1991
- 1991-06-03 GB GB919111902A patent/GB9111902D0/en active Pending
-
1992
- 1992-02-06 UA UA93004068A patent/UA41265C2/uk unknown
- 1992-06-02 IL IL10207392A patent/IL102073A/en not_active IP Right Cessation
- 1992-06-02 NO NO922182A patent/NO301713B1/no not_active IP Right Cessation
- 1992-06-02 ZA ZA924007A patent/ZA924007B/xx unknown
- 1992-06-02 ES ES92109221T patent/ES2171158T3/es not_active Expired - Lifetime
- 1992-06-02 DE DE69232387T patent/DE69232387T2/de not_active Expired - Lifetime
- 1992-06-02 NZ NZ242981A patent/NZ242981A/en not_active IP Right Cessation
- 1992-06-02 SK SK1257-93A patent/SK281249B6/sk not_active IP Right Cessation
- 1992-06-02 AU AU17361/92A patent/AU656379B2/en not_active Expired
- 1992-06-02 EP EP92109221A patent/EP0517145B1/en not_active Expired - Lifetime
- 1992-06-02 IS IS3873A patent/IS1867B/is unknown
- 1992-06-02 CZ CS932612A patent/CZ284513B6/cs not_active IP Right Cessation
- 1992-06-02 AT AT92109221T patent/ATE212630T1/de active
- 1992-06-02 SG SG1996004763A patent/SG52455A1/en unknown
- 1992-06-02 DK DK92109221T patent/DK0517145T3/da active
- 1992-06-02 GE GEAP19922654A patent/GEP19991834B/en unknown
- 1992-06-02 JP JP4166809A patent/JP2851480B2/ja not_active Expired - Lifetime
- 1992-06-02 CA CA002311988A patent/CA2311988C/en not_active Expired - Lifetime
- 1992-06-02 RU RU93058495A patent/RU2102393C1/ru active
- 1992-06-02 AP APAP/P/1992/000395A patent/AP300A/en active
- 1992-06-02 US US07/892,029 patent/US5905082A/en not_active Expired - Lifetime
- 1992-06-02 TW TW081104300A patent/TW254939B/zh not_active IP Right Cessation
- 1992-06-02 MX MX9202619A patent/MX9202619A/es active IP Right Grant
- 1992-06-02 EP EP01200491A patent/EP1099700A1/en not_active Withdrawn
- 1992-06-02 PT PT92109221T patent/PT517145E/pt unknown
- 1992-06-02 KR KR1019920009537A patent/KR100244008B1/ko not_active IP Right Cessation
- 1992-06-02 WO PCT/EP1992/001213 patent/WO1992021676A1/en active IP Right Grant
- 1992-06-02 AU AU18810/92A patent/AU1881092A/en not_active Abandoned
- 1992-06-02 CA CA002070230A patent/CA2070230C/en not_active Expired - Lifetime
- 1992-07-01 IE IE178092A patent/IE921780A1/en not_active IP Right Cessation
- 1992-07-01 IE IE20020782A patent/IE20020782A1/en not_active IP Right Cessation
- 1992-12-04 IS IS4268A patent/IS4268A/is unknown
-
1993
- 1993-11-15 OA OA60437A patent/OA09913A/en unknown
- 1993-11-30 BG BG98254A patent/BG60914B1/bg unknown
-
1998
- 1998-08-31 HK HK98110312A patent/HK1009599A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69208877T2 (de) | Chinuclidinderivate | |
NO922182L (no) | Krystallinske oksatiolan-derivater | |
DE69119329D1 (de) | Actinonin-Derivate | |
ATE137279T1 (de) | Stoffauflauf | |
ATA75293A (de) | Indolderivate | |
FI925523A (fi) | Hydroxi- och alkoxipyridinderivat | |
FI925763A0 (fi) | Fungicida 2-imidazolin-5-on- och 2-imidazolin-5-tionderivat | |
DE69125099T2 (de) | Indolderivate | |
ATE144765T1 (de) | Hiv-hemmende benzenacetamidderivate | |
DE69330497D1 (de) | Chinazolin-derivate | |
ATA131391A (de) | Reibring | |
ATE171449T1 (de) | Oxadolderivate | |
DE59308714D1 (de) | Cyclobutan-benzol-derivate | |
DK0472733T3 (da) | Phenantrenderivater | |
TR26336A (tr) | SüBSTITüE EDILMIS PIRAZOLIN TüREVLERI | |
NO920420D0 (no) | 3-quinuklidin-derivater | |
FI925469A (fi) | Tiazolylsubstituerade kinolylymetoxifenylaettiksyraderivat | |
NO952288D0 (no) | Benzazepinon-derivater | |
DE69313890T2 (de) | 5-Aminoflavon-Derivate | |
MX9206710A (es) | Derivados de piridinol | |
ATA39792A (de) | Maehwerk | |
DE69211197D1 (de) | 1-Hydroxyvitamin D-Derivate | |
ATE163916T1 (de) | Ethyl-6-formyloxy-4-hexenoat | |
KR930702353A (ko) | 2- 카르바페넴 유도체 | |
ATA9892A (de) | Formstein |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK1K | Patent expired |